Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
about
Novel Molecular Markers for Breast CancerAutophagy and Apoptotic Crosstalk: Mechanism of Therapeutic Resistance in HER2-Positive Breast CancerHyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44Haploinsufficient tumor suppressor genes.Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.A summary of relationships between alternative splicing and breast cancer.Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancerClinical applications of mouse models for breast cancer engaging HER2/neu.Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling.Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated?Alternative Splicing as a Target for Cancer Treatment.HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5′ Splice Site.A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
P2860
Q26753160-7F3B0B2F-A894-45D0-A93F-E1DDA8D0066AQ26753162-5D04CFA4-5768-4A83-A7B7-AFA0B7439536Q28566589-61402053-C8B6-4C28-A397-F7290066D44BQ33864922-08A3AE05-14C3-4656-8805-50EC334DDC5BQ36091457-777434E2-965A-4BA3-8332-EB68DED54F9DQ36378283-4E125392-DD34-40A5-839C-2EEBBE90F927Q37306546-816DBF3C-6D80-48E8-9AC4-CEB33F48C668Q37607675-08E8CE36-2747-4793-AD0B-8BBE79EDB7A3Q38838490-0B7D7693-5126-4365-86AC-51BE13A7100DQ38935156-53C8DBD8-965D-417F-B0B5-069B4B510216Q41520586-00894740-56C3-47E1-A8D2-E920689FEFBCQ44262180-B4CA5C91-216A-4BAF-A511-74624D992ACAQ47110708-9C652DFF-6316-4B34-A614-45AAA18DBEEFQ47131767-077C2A5B-FAE2-460A-AF00-5538763D1F76Q50033988-1E28D179-1E51-42A9-B951-1C45A70B7395Q55254725-E0A16B19-0C0D-465A-ACEC-F931E9EED8C5Q58754066-78B0023A-EDBB-4724-AE83-AE53229FA7AE
P2860
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@ast
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@en
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@nl
type
label
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@ast
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@en
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@nl
prefLabel
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@ast
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@en
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@nl
P2860
P3181
P356
P1476
Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer
@en
P2093
Elizabeth A Fry
Kazushi Inoue
P2860
P3181
P356
10.4137/GEG.S35500
P407
P577
2015-01-01T00:00:00Z